Concepedia

Publication | Closed Access

Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus

DOI

27

Citations

25

References

2011

Year

Yasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, Yoshiyuki Suzuki, Yusuke Kawamura, Naoki Matsumoto, Norio Akuta, Norihisa Imai, Masahiro Kobayashi, Hitomi Sezaki,
Hepatology Research

Abstract

Our results indicate that sitagliptin is effective and safe for the treatment of T2DM complicated with HCV positive chronic liver disease.

References

YearCitations

Page 1